[Comment] Ralinepag in pulmonary arterial hypertension: a step forward | ClinicLens
In the past few decades, treatment of pulmonary arterial hypertension (PAH) has seen vast growth, resulting in numerous drugs being approved for the management of this devastating condition. The presumed result of these changes in treatment strategy, including initiation of upfro
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.